Trio Pharmaceuticals is a cancer therapeutics company developing dual-action antibody drugs. Its TRIO™ platform creates antibody-drug conjugates (ADCs) that not only deliver cytotoxic payloads directly to tumor cells but also stimulate the immune system to fight cancer.
